0000929638-25-002591.txt : 20250715 0000929638-25-002591.hdr.sgml : 20250715 20250715113253 ACCESSION NUMBER: 0000929638-25-002591 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20250715 DATE AS OF CHANGE: 20250715 EFFECTIVENESS DATE: 20250715 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NEUTROLIS INC. CENTRAL INDEX KEY: 0001788926 ORGANIZATION NAME: EIN: 822144641 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-551762 FILM NUMBER: 251123728 BUSINESS ADDRESS: STREET 1: 1 BROADWAY, FLOOR 14 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 857-930-3397 MAIL ADDRESS: STREET 1: 1 BROADWAY, FLOOR 14 CITY: CAMBRIDGE STATE: MA ZIP: 02142 D 1 primary_doc.xml X0708 D LIVE 0001788926 NEUTROLIS INC. 1 BROADWAY, FLOOR 14 CAMBRIDGE MA MASSACHUSETTS 02142 857-930-3397 DELAWARE Neutrolis Therapeutics, Inc. None Corporation true Abdul Hakkim Rahamathullah 1 Broadway, Floor 14 Cambridge MA MASSACHUSETTS 02142 Director Executive Officer Promoter Mr. Rahamathullah is also the Co-Founder, Co-President and Treasurer of the Issuer. Toby Fox 1 Broadway, Floor 14 Cambridge MA MASSACHUSETTS 02142 Director Executive Officer Promoter Mr. Fox is also the Co-Founder, Co-President and Secretary of the Issuer. Gerald Chan 1 Broadway, Floor 14 Cambridge MA MASSACHUSETTS 02142 Director Anthony Aiudi 1 Broadway, Floor 14 Cambridge MA MASSACHUSETTS 02142 Director Executive Officer Promoter Mr. Aiudi is Chief Executive Officer of the Issuer. John Sundy 1 Broadway, Floor 14 Cambridge MA MASSACHUSETTS 02142 Director Biotechnology Decline to Disclose 06b false 2025-06-20 false true true false 0 10000000 3500000 6500000 false 1 0 0 0 false NEUTROLIS INC. /s/ Anthony Aiudi Anthony Aiudi Chief Executive Officer of the Issuer 2025-07-08